M. J. A. Mustafa, M. B. Mohamed, and A. Hayat, “Tumour Lysis Syndrome and Partial Remission Occurring After Administration of a Test Dose of Obinutuzumab”, EJCRIM, vol. 4, no. 1, Jan. 2017.